Literature DB >> 24091309

Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.

Jelena Põlajeva1, Tobias Bergström2, Per-Henrik Edqvist3, Anders Lundequist4, Anna Sjösten5, Gunnar Nilsson6, Anja Smits7, Michael Bergqvist8, Fredrik Pontén9, Bengt Westermark10, Gunnar Pejler11, Karin Forsberg Nilsson12, Elena Tchougounova13.   

Abstract

Recently, glioma research has increased its focus on the diverse types of cells present in brain tumors. We observed previously that gliomas are associated with a profound accumulation of mast cells (MCs) and here we investigate the underlying mechanism. Gliomas express a plethora of chemoattractants. First, we demonstrated pronounced migration of human MCs toward conditioned medium from cultures of glioma cell lines. Subsequent cytokine array analyses of media from cells, cultured in either serum-containing or -free conditions, revealed a number of candidates which were secreted in high amounts in both cell lines. Among these, we then focused on macrophage migration inhibitory factor (MIF), which has been reported to be pro-inflammatory and -tumorigenic. Infiltration of MCs was attenuated by antibodies that neutralized MIF. Moreover, a positive correlation between the number of MCs and the level of MIF in a large cohort of human glioma tissue samples was observed. Further, both glioma-conditioned media and purified MIF promoted differential phosphorylation of a number of signaling molecules, including signal transducer and activator of transcription 5 (STAT5), in MCs. Inhibition of pSTAT5 signaling significantly attenuated the migration of MCs toward glioma cell-conditioned medium shown to contain MIF. In addition, analysis of tissue microarrays (TMAs) of high-grade gliomas revealed a direct correlation between the level of pSTAT5 in MCs and the level of MIF in the medium. In conclusion, these findings indicate the important influence of signaling cascades involving MIF and STAT5 on the recruitment of MCs to gliomas.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BBB; CBMC; CF; CI; GBM; Glioma; IHC; MC; MIF; Mast cell; STAT; TMA; blood–brain barrier; cord blood mast cell; cytoplasmic fraction; cytoplasmic intensity; glioblastoma multiforme; immunohistochemistry; mast cell; microphage migration inhibitory factor; pSTAT5; signal transducer and activator of transcription; tissue microarray

Mesh:

Substances:

Year:  2013        PMID: 24091309      PMCID: PMC5528513          DOI: 10.1016/j.molonc.2013.09.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  30 in total

1.  Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.

Authors:  Matthew J Strouch; Eric C Cheon; Mohammad R Salabat; Seth B Krantz; Elias Gounaris; Laleh G Melstrom; Surabhi Dangi-Garimella; Edward Wang; Hidayatullah G Munshi; Khashayarsha Khazaie; David J Bentrem
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

2.  Towards a knowledge-based Human Protein Atlas.

Authors:  Mathias Uhlen; Per Oksvold; Linn Fagerberg; Emma Lundberg; Kalle Jonasson; Mattias Forsberg; Martin Zwahlen; Caroline Kampf; Kenneth Wester; Sophia Hober; Henrik Wernerus; Lisa Björling; Fredrik Ponten
Journal:  Nat Biotechnol       Date:  2010-12       Impact factor: 54.908

3.  Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.

Authors:  N Lindberg; M Kastemar; T Olofsson; A Smits; L Uhrbom
Journal:  Oncogene       Date:  2009-04-27       Impact factor: 9.867

4.  Constitutive Akt1 signals attenuate B-cell receptor signaling and proliferation, but enhance B-cell migration and effector function.

Authors:  Mandy Pierau; Shin-Young Na; Narasimhulu Simma; Theresa Lowinus; Alexander Marx; Burkhart Schraven; Ursula H Bommhardt
Journal:  Eur J Immunol       Date:  2012-12       Impact factor: 5.532

Review 5.  Microglial action in glioma: a boon turns bane.

Authors:  Anirban Ghosh; Swapna Chaudhuri
Journal:  Immunol Lett       Date:  2010-03-23       Impact factor: 3.685

Review 6.  New molecular targets in angiogenic vessels of glioblastoma tumours.

Authors:  Joshua C Anderson; Braden C McFarland; Candece L Gladson
Journal:  Expert Rev Mol Med       Date:  2008-08-07       Impact factor: 5.600

7.  Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation.

Authors:  Frida Mowafi; Alberto Cagigi; Ludmila Matskova; Olle Björk; Francesca Chiodi; Anna Nilsson
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

Review 8.  Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

Authors:  B M Jensen; C Akin; A M Gilfillan
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

9.  Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas.

Authors:  Caroline Kampf; Ingmarie Olsson; Urban Ryberg; Evelina Sjöstedt; Fredrik Pontén
Journal:  J Vis Exp       Date:  2012-05-31       Impact factor: 1.355

10.  Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.

Authors:  Jelena Põlajeva; Anna M Sjösten; Nina Lager; Marianne Kastemar; Ida Waern; Irina Alafuzoff; Anja Smits; Bengt Westermark; Gunnar Pejler; Lene Uhrbom; Elena Tchougounova
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

View more
  18 in total

Review 1.  Multidimensional communication in the microenvirons of glioblastoma.

Authors:  Marike L Broekman; Sybren L N Maas; Erik R Abels; Thorsten R Mempel; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

2.  Comparative dynamics of microglial and glioma cell motility at the infiltrative margin of brain tumours.

Authors:  Joseph Juliano; Orlando Gil; Andrea Hawkins-Daarud; Sonal Noticewala; Russell C Rockne; Jill Gallaher; Susan Christine Massey; Peter A Sims; Alexander R A Anderson; Kristin R Swanson; Peter Canoll
Journal:  J R Soc Interface       Date:  2018-02       Impact factor: 4.118

3.  Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.

Authors:  Jelena Põlajeva; Tobias Bergström; Per-Henrik Edqvist; Anders Lundequist; Anna Sjösten; Gunnar Nilsson; Anja Smits; Michael Bergqvist; Fredrik Pontén; Bengt Westermark; Gunnar Pejler; Karin Forsberg Nilsson; Elena Tchougounova
Journal:  Mol Oncol       Date:  2013-09-18       Impact factor: 6.603

4.  Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.

Authors:  Balint Otvos; Daniel J Silver; Erin E Mulkearns-Hubert; Alvaro G Alvarado; Soumya M Turaga; Mia D Sorensen; Patricia Rayman; William A Flavahan; James S Hale; Kevin Stoltz; Maksim Sinyuk; Qiulian Wu; Awad Jarrar; Sung-Hak Kim; Paul L Fox; Ichiro Nakano; Jeremy N Rich; Richard M Ransohoff; James Finke; Bjarne W Kristensen; Michael A Vogelbaum; Justin D Lathia
Journal:  Stem Cells       Date:  2016-05-27       Impact factor: 6.277

Review 5.  The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions.

Authors:  Kelly Mitchell; Katie Troike; Daniel J Silver; Justin D Lathia
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

Review 6.  Mast cells in meningiomas and brain inflammation.

Authors:  Stavros Polyzoidis; Triantafyllia Koletsa; Smaro Panagiotidou; Keyoumars Ashkan; Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

7.  Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells.

Authors:  Ananya Roy; Antoine Coum; Voichita D Marinescu; Jelena Põlajeva; Anja Smits; Sven Nelander; Lene Uhrbom; Bengt Westermark; Karin Forsberg-Nilsson; Fredrik Pontén; Elena Tchougounova
Journal:  Oncotarget       Date:  2015-09-15

8.  Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.

Authors:  Ananya Roy; Sanaz Attarha; Holger Weishaupt; Per-Henrik Edqvist; Fredrik J Swartling; Michael Bergqvist; Florian A Siebzehnrubl; Anja Smits; Fredrik Pontén; Elena Tchougounova
Journal:  Oncotarget       Date:  2017-04-11

9.  Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells.

Authors:  Yashi Gupta; Vinay Pasupuleti; Weinan Du; Scott M Welford
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

10.  Macrophage Migration Inhibitory Factor (MIF) Prevents Maternal Death, but Contributes to Poor Fetal Outcome During Congenital Toxoplasmosis.

Authors:  Angelica O Gomes; Bellisa F Barbosa; Priscila S Franco; Mayara Ribeiro; Rafaela J Silva; Paula S G Gois; Karine C Almeida; Mariana B Angeloni; Andressa S Castro; Pâmela M Guirelli; João V Cândido; Javier E L Chica; Neide M Silva; Tiago W P Mineo; José R Mineo; Eloisa A V Ferro
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.